JP2022528053A5 - - Google Patents
Info
- Publication number
- JP2022528053A5 JP2022528053A5 JP2021557014A JP2021557014A JP2022528053A5 JP 2022528053 A5 JP2022528053 A5 JP 2022528053A5 JP 2021557014 A JP2021557014 A JP 2021557014A JP 2021557014 A JP2021557014 A JP 2021557014A JP 2022528053 A5 JP2022528053 A5 JP 2022528053A5
- Authority
- JP
- Japan
- Prior art keywords
- psma
- binding protein
- binding
- seq
- protein according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19168525.4 | 2019-04-10 | ||
| EP19168525 | 2019-04-10 | ||
| PCT/EP2020/060043 WO2020208083A1 (en) | 2019-04-10 | 2020-04-08 | Novel psma specific binding proteins for cancer diagnosis and treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022528053A JP2022528053A (ja) | 2022-06-08 |
| JP2022528053A5 true JP2022528053A5 (enExample) | 2024-02-22 |
| JP7498971B2 JP7498971B2 (ja) | 2024-06-13 |
Family
ID=66286079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557014A Active JP7498971B2 (ja) | 2019-04-10 | 2020-04-08 | がん診断及び治療のための新規ｐｓｍａ特異的結合タンパク質 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12611441B2 (enExample) |
| EP (2) | EP4108680B1 (enExample) |
| JP (1) | JP7498971B2 (enExample) |
| KR (1) | KR102934740B1 (enExample) |
| CN (1) | CN113677698B (enExample) |
| AU (1) | AU2020271959B2 (enExample) |
| BR (1) | BR112021017863A2 (enExample) |
| CA (1) | CA3136229A1 (enExample) |
| IL (1) | IL286791A (enExample) |
| SG (1) | SG11202110940YA (enExample) |
| WO (1) | WO2020208083A1 (enExample) |
| ZA (1) | ZA202108843B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023285164A1 (en) * | 2021-07-13 | 2023-01-19 | Navigo Proteins Gmbh | Affinity ligands for the purification and detection of ubiquitin muteins |
| CN114569744A (zh) * | 2022-03-08 | 2022-06-03 | 安徽淮仁堂药业股份有限公司 | 一种锝前列腺标特异性膜抗原显像剂试剂盒及其制备方法和应用 |
| CN116041435B (zh) * | 2023-02-21 | 2023-07-07 | 浙江农林大学 | 一种具有2019新型冠状病毒主蛋白酶抑制活性的榛仁蛋白衍生肽及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003035839A2 (en) * | 2001-10-24 | 2003-05-01 | Dgi Biotechnologies, Inc. | Target specific screening andits use for identifying target binders |
| US7749968B2 (en) * | 2002-08-05 | 2010-07-06 | The Johns Hopkins University | Peptides for targeting the prostate specific membrane antigen |
| DE10324447A1 (de) * | 2003-05-28 | 2004-12-30 | Scil Proteins Gmbh | Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin |
| BR112012014417B1 (pt) | 2009-12-14 | 2021-11-09 | Scil Proteins Gmbh | Proteínas ubiquitinas modificadas tendo uma atividade de ligação específica para o extradomínio b de fibronectina |
| WO2012171541A1 (en) | 2011-06-15 | 2012-12-20 | Scil Proteins Gmbh | Human fusion proteins comprising interferons and hetero-dimeric modified ubiquitin proteins |
| EP3253785B1 (en) * | 2015-02-06 | 2019-04-10 | Navigo Proteins Gmbh | Novel egfr binding proteins |
| US20180030140A1 (en) | 2015-02-06 | 2018-02-01 | Navigo Proteins Gmbh | Novel binding proteins comprising a ubiquitin mutein and antibodies or antibody fragments |
| JP7366518B2 (ja) * | 2015-05-06 | 2023-10-23 | ヤンセン バイオテツク，インコーポレーテツド | 前立腺特異的膜抗原結合フィブロネクチンｉｉｉ型ドメイン |
| CN107849147B (zh) * | 2015-07-20 | 2021-09-17 | 纳维格蛋白质有限公司 | 基于二泛素突变蛋白的Her2结合蛋白 |
| JP2018520675A (ja) * | 2015-07-20 | 2018-08-02 | ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングＮａｖｉｇｏ Ｐｒｏｔｅｉｎｓ ＧｍｂＨ | ジユビキチン変異タンパク質をベースとした新規結合タンパク質及びその生成方法 |
| WO2017149002A1 (en) * | 2016-03-03 | 2017-09-08 | Navigo Proteins Gmbh | Novel fusion proteins for capturing of cells |
| WO2023285164A1 (en) * | 2021-07-13 | 2023-01-19 | Navigo Proteins Gmbh | Affinity ligands for the purification and detection of ubiquitin muteins |
-
2020
- 2020-04-08 US US17/602,729 patent/US12611441B2/en active Active
- 2020-04-08 EP EP22180667.2A patent/EP4108680B1/en active Active
- 2020-04-08 CN CN202080027745.0A patent/CN113677698B/zh active Active
- 2020-04-08 WO PCT/EP2020/060043 patent/WO2020208083A1/en not_active Ceased
- 2020-04-08 BR BR112021017863A patent/BR112021017863A2/pt unknown
- 2020-04-08 KR KR1020217036594A patent/KR102934740B1/ko active Active
- 2020-04-08 JP JP2021557014A patent/JP7498971B2/ja active Active
- 2020-04-08 EP EP20716487.2A patent/EP3953375B9/en active Active
- 2020-04-08 SG SG11202110940YA patent/SG11202110940YA/en unknown
- 2020-04-08 AU AU2020271959A patent/AU2020271959B2/en active Active
- 2020-04-08 CA CA3136229A patent/CA3136229A1/en active Pending
-
2021
- 2021-09-29 IL IL286791A patent/IL286791A/en unknown
- 2021-11-09 ZA ZA2021/08843A patent/ZA202108843B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7417432B2 (ja) | 新規リンカー、その製造方法およびその応用 | |
| JP3280376B2 (ja) | 多価抗原結合性蛋白質 | |
| JP7291395B2 (ja) | ＩｇＧ結合ペプチド、及び該ペプチドによる抗体の特異的修飾 | |
| JP2022065174A5 (enExample) | ||
| JP2021502810A5 (enExample) | ||
| JP7680745B2 (ja) | １価ｃｃａｐ生成物の製造方法 | |
| JP2021521822A5 (enExample) | ||
| JPH02500329A (ja) | ターゲット化多機能蛋白質 | |
| WO2002066514A3 (en) | Artificial fusion proteins with reduced immunogenicity | |
| CN105142675A (zh) | 通过序列特异性转肽酶制备免疫配体/效应分子结合物的方法 | |
| JP2020530285A5 (enExample) | ||
| CA2304254A1 (en) | Trimerising module | |
| JPH0259128B2 (enExample) | ||
| CA2288992A1 (en) | Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof | |
| JPH05502880A (ja) | トランスロケーション領域および細胞結合領域を有するハイブリッド分子 | |
| JP2019511201A5 (enExample) | ||
| JP2024507540A5 (enExample) | ||
| JP2024508969A5 (enExample) | ||
| JP2000510454A (ja) | カルシウム依存性結合タンパク質の改変されたリガンド | |
| JP2024513559A5 (enExample) | ||
| AU6757098A (en) | Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels | |
| JP5718574B2 (ja) | ペプチドのスクリーニング方法 | |
| JP7498971B2 (ja) | がん診断及び治療のための新規ｐｓｍａ特異的結合タンパク質 | |
| Remy et al. | A new radioligand for the epidermal growth factor receptor: 111In-labeled human epidermal growth factor derivatized with a bifunctional metal-chelating peptide | |
| JP2019523782A5 (enExample) |